Skip to main content
Top
Published in: Tumor Biology 5/2014

01-05-2014 | Research Article

RETRACTED ARTICLE: The prognosis and clinicopathology of CXCR4 in gastric cancer patients: a meta-analysis

Authors: Mingzhi Han, Shunzeng Lv, Ya Zhang, Ruiyang Yi, Bin Huang, Hanhui Fu, Ruixiang Bian, Xingang Li

Published in: Tumor Biology | Issue 5/2014

Login to get access

Abstract

The chemokine receptor 4 (CXCR4) has been widely investigated in diagnosis and prognosis of gastric cancer (GC). However, the impact of CXCR4 on GC patients remains controversial; Here, we conducted a meta-analysis to obtain the precise role of CXCR4 in GC prognosis and clinicopathology. Thirteen published studies with a total of 1,936 patients were included. Original data included the hazard ratio (HR) of overall survival (OS) and odds ratio (OR) in GC patients. We combined HR/OR with 95 % confidence interval (CI) to estimate the hazard. In this study, OS was significantly related to CXCR4 expression, with the HR 2.63 (95 % CI 1.69–4.09; p < 0.0001), and a significant correlation was also revealed between CXCR4 expression and stage (I + II, +) (OR 0.52, 95 % CI 0.32–0.83; p = 0.007), depth of invasion (T1/T2, +) (OR 0.44, 95 % CI 0.27–0.73; p = 0.001), lymph node metastasis (LN, +) (OR 2.30, 95 % CI 1.57–3.36; p < 0.0001), as well as vascular invasion (vas.inv, +) (OR 0.72, 95 % CI 0.53–0.98; p = 0.04). Heterogeneity was observed among the included studies with OS (I 2 = 51 %), stage (I 2 = 78 %), depth of invasion (I 2 = 74 %), lymph node metastasis (I 2 = 64 %), and histology differentiation (I 2 = 79 %). No publication bias was observed. In conclusion, this meta-analysis showed CXCR4 expression indicates poor prognosis in GC patients with advanced stage or deep invasion in GC tissues, which also implied lymph node metastasis and vascular invasion. Thus, CXCR4 could help predict patient prognosis and guide clinical diagnosis and treatment.
Literature
2.
go back to reference Yoshie O, ImaiT NH. Novel lymphocyte-specific CC chemokines and their receptors. J Leukoc Biol. 1997;62:634–44.PubMed Yoshie O, ImaiT NH. Novel lymphocyte-specific CC chemokines and their receptors. J Leukoc Biol. 1997;62:634–44.PubMed
3.
go back to reference Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410:50–6.CrossRefPubMed Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410:50–6.CrossRefPubMed
4.
go back to reference Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, McCauley LK. Use of the stromal cell-derived factor-1alpha/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res. 2002;62:1832–7.PubMed Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, McCauley LK. Use of the stromal cell-derived factor-1alpha/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res. 2002;62:1832–7.PubMed
5.
go back to reference Oonakahara K, Matsuyama W, Higashimoto I, Kawabata M, Arimura K, Osame M. Stromal-derived factor-1alpha/CXCL12-CXCR4 axis is involved in the dissemination of NS CLC cells into pleural space. Am J Respir Cell Mol Biol. 2004;30:671–7.CrossRefPubMed Oonakahara K, Matsuyama W, Higashimoto I, Kawabata M, Arimura K, Osame M. Stromal-derived factor-1alpha/CXCL12-CXCR4 axis is involved in the dissemination of NS CLC cells into pleural space. Am J Respir Cell Mol Biol. 2004;30:671–7.CrossRefPubMed
6.
go back to reference Kim J, Mori T, Chen SL, Amersi FF, Martinez SR, Kuo C, et al. Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann Surg. 2006;244:113–20.CrossRefPubMedPubMedCentral Kim J, Mori T, Chen SL, Amersi FF, Martinez SR, Kuo C, et al. Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann Surg. 2006;244:113–20.CrossRefPubMedPubMedCentral
7.
go back to reference Zhao BC, Wang ZJ, Mao WZ, Ma HC, Han JG, Zhao B, et al. CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma. World J Gastroenterol. 2011;17:2389–96.CrossRefPubMedPubMedCentral Zhao BC, Wang ZJ, Mao WZ, Ma HC, Han JG, Zhao B, et al. CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma. World J Gastroenterol. 2011;17:2389–96.CrossRefPubMedPubMedCentral
8.
go back to reference Lee HJ, Kim SW, Kim HY, Li S, Yun HJ, Song KS, et al. Chemokine receptor CXCR4 expression, function and clinical implications in gastric cancer. Int J Oncol. 2009;34:473–80.PubMed Lee HJ, Kim SW, Kim HY, Li S, Yun HJ, Song KS, et al. Chemokine receptor CXCR4 expression, function and clinical implications in gastric cancer. Int J Oncol. 2009;34:473–80.PubMed
9.
go back to reference Sun TY, Yan W, Zhao YL, Yu PW. CXCR4 expression in gastric cancer and its clinical significance. Chin J Oper Proc Gen Surg. 2011;5:182–7. Sun TY, Yan W, Zhao YL, Yu PW. CXCR4 expression in gastric cancer and its clinical significance. Chin J Oper Proc Gen Surg. 2011;5:182–7.
10.
go back to reference Tsuboi K, Kodera Y, Nakanishi H, Ito S, Mochizuki Y, Nakayama G, et al. Expression of CXCL12 and CXCR4 in pT3-stage gastric cancer does not correlate with peritoneal metastasis. Oncol Rep. 2008;20:1117–23.PubMed Tsuboi K, Kodera Y, Nakanishi H, Ito S, Mochizuki Y, Nakayama G, et al. Expression of CXCL12 and CXCR4 in pT3-stage gastric cancer does not correlate with peritoneal metastasis. Oncol Rep. 2008;20:1117–23.PubMed
11.
go back to reference Zou P, Zhang ZY, Wu JF. Expressions of chemokine CXCL12 and its receptor CXCR4 in gastric cancer and their significance. J Clin Exp Pathal. 2012;28:265–9. Zou P, Zhang ZY, Wu JF. Expressions of chemokine CXCL12 and its receptor CXCR4 in gastric cancer and their significance. J Clin Exp Pathal. 2012;28:265–9.
12.
go back to reference Steels E, Paesmans M, Berghmans T, Branle F, Lemaitre F, Mascaux C, et al. Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. Eur Respir J. 2001;18:705–19.CrossRefPubMed Steels E, Paesmans M, Berghmans T, Branle F, Lemaitre F, Mascaux C, et al. Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. Eur Respir J. 2001;18:705–19.CrossRefPubMed
13.
go back to reference Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.CrossRefPubMedPubMedCentral Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.CrossRefPubMedPubMedCentral
14.
go back to reference Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815–34.CrossRefPubMed Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815–34.CrossRefPubMed
16.
go back to reference Arigami T, Natsugoe S, Uenosono Y, Yanagita S, Arima H, Hirata M, et al. CCR7 and CXCR4 expression predicts lymph node status including micrometastasis in gastric cancer. Int J Oncol. 2009;35:19–24.CrossRefPubMed Arigami T, Natsugoe S, Uenosono Y, Yanagita S, Arima H, Hirata M, et al. CCR7 and CXCR4 expression predicts lymph node status including micrometastasis in gastric cancer. Int J Oncol. 2009;35:19–24.CrossRefPubMed
17.
go back to reference Lee HJ, Huang SM, Kim HY, Oh YS, Hwang JY, Liang ZL, et al. Evaluation of the combined expression of chemokine SDF-1 α and its receptor CXCR4 as a prognostic marker for gastric cancer. Exp Ther Med. 2011;2:499–504.CrossRefPubMedPubMedCentral Lee HJ, Huang SM, Kim HY, Oh YS, Hwang JY, Liang ZL, et al. Evaluation of the combined expression of chemokine SDF-1 α and its receptor CXCR4 as a prognostic marker for gastric cancer. Exp Ther Med. 2011;2:499–504.CrossRefPubMedPubMedCentral
18.
go back to reference Ying J, Xu Q, Zhang G, Liu B, Zhu L. The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis. Med Oncol. 2012;29:1716–22.CrossRefPubMed Ying J, Xu Q, Zhang G, Liu B, Zhu L. The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis. Med Oncol. 2012;29:1716–22.CrossRefPubMed
19.
go back to reference Zhu ZQ, Ning ZL, Shao F, Hu B. Liang W (2012) Expression of CXCR4 in gastric cancer and its relationship with patient prognosis. Acad J Sec Mil Med Univ. 2012;33:43–7.CrossRef Zhu ZQ, Ning ZL, Shao F, Hu B. Liang W (2012) Expression of CXCR4 in gastric cancer and its relationship with patient prognosis. Acad J Sec Mil Med Univ. 2012;33:43–7.CrossRef
20.
go back to reference Kwak MK, Hur K, Park DJ, Lee HJ, Lee HS, Kim WH, et al. Expression of chemokine receptors in human gastric cancer. Tumor Biol. 2005;26:65–70.CrossRef Kwak MK, Hur K, Park DJ, Lee HJ, Lee HS, Kim WH, et al. Expression of chemokine receptors in human gastric cancer. Tumor Biol. 2005;26:65–70.CrossRef
21.
go back to reference He H, Wang C, Shen Z, Fang Y, Wang X, Chen W, et al. Upregulated expression of C-X-C chemokine receptor 4 is an independent prognostic predictor for patients with gastric cancer. Plos ONE. 2013;8:e71864.CrossRefPubMedPubMedCentral He H, Wang C, Shen Z, Fang Y, Wang X, Chen W, et al. Upregulated expression of C-X-C chemokine receptor 4 is an independent prognostic predictor for patients with gastric cancer. Plos ONE. 2013;8:e71864.CrossRefPubMedPubMedCentral
22.
go back to reference Ingold B, Simon E, Ungethüm U, Kuban RJ, Müller BM, Lupp A, et al. Vascular CXCR4 expression—a novel antiangiogenic target in gastric cancer? Plos ONE. 2010;5:e10087.CrossRefPubMedPubMedCentral Ingold B, Simon E, Ungethüm U, Kuban RJ, Müller BM, Lupp A, et al. Vascular CXCR4 expression—a novel antiangiogenic target in gastric cancer? Plos ONE. 2010;5:e10087.CrossRefPubMedPubMedCentral
23.
24.
go back to reference Ratajczak MZ, Zuba-Surma E, Kucia M, Reca R, Wojakowski W, Ratajczak J. The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia. 2006;20:1915–24.CrossRefPubMed Ratajczak MZ, Zuba-Surma E, Kucia M, Reca R, Wojakowski W, Ratajczak J. The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia. 2006;20:1915–24.CrossRefPubMed
25.
go back to reference Begg CB, Berlin JA. Publication bias: a problem in interpreting medical data. J R Stat Soc A. 1988;81:107–15. Begg CB, Berlin JA. Publication bias: a problem in interpreting medical data. J R Stat Soc A. 1988;81:107–15.
26.
go back to reference Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.CrossRefPubMed Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.CrossRefPubMed
Metadata
Title
RETRACTED ARTICLE: The prognosis and clinicopathology of CXCR4 in gastric cancer patients: a meta-analysis
Authors
Mingzhi Han
Shunzeng Lv
Ya Zhang
Ruiyang Yi
Bin Huang
Hanhui Fu
Ruixiang Bian
Xingang Li
Publication date
01-05-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 5/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-1603-4

Other articles of this Issue 5/2014

Tumor Biology 5/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine